SCHEMBL9762902

SCHEMBL9762902

OCCCc1ccc(CCCOCCCCCCBr)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP4A11 Q02928 2/20 0.45
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
USP2 O75604 1/20 0.42
ALDH1A1 P00352 1/20 0.42
LMNA P02545 1/20 0.42
CYP3A4 P08684 1/20 0.42
MAPK1 P28482 1/20 0.42
CASP1 P29466 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
SLCO1B3 Q9NPD5 1/20 0.42
SLCO1B1 Q9Y6L6 1/20 0.42
LTA4H P09960 1/20 0.40
EPHX2 P34913 1/20 0.40
CYP4F2 P78329 1/20 0.40
CA2 P00918 3/20 0.40
PPARA Q07869 1/20 0.37
THRA P10827 1/20 0.37
THRB P10828 1/20 0.37
TDP1 Q9NUW8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9763640 0.89 MEN1 (0.39) CYP4A11MEN1KMT2AUSP2ALDH1A1
SCHEMBL9762727 0.85 TDP1 (0.38) MEN1KMT2AUSP2ALDH1A1LMNA
SCHEMBL9763690 0.84 TAAR1 (0.41) MEN1KMT2AUSP2ALDH1A1LMNA
SCHEMBL4939834 0.82 LTA4H (0.56) CYP4A11MEN1KMT2AUSP2ALDH1A1
SCHEMBL20317448 0.82 MEN1 (0.45) CYP4A11MEN1KMT2AUSP2ALDH1A1
SCHEMBL9574237 0.82 TAAR1 (0.39) MEN1KMT2ATHRATHRBTDP1
SCHEMBL9574249 0.81 IDO1 (0.52) MEN1KMT2ALMNATDP1L3MBTL1
SCHEMBL9257411 0.81 IDO1 (0.52) MEN1KMT2ALMNATDP1L3MBTL1
SCHEMBL9262777 0.81 IDO1 (0.52) MEN1KMT2ALMNATDP1L3MBTL1
SCHEMBL9763639 0.81 RARB (0.50) CYP4A11MEN1KMT2AALDH1A1CYP4F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4990505-A Treating asthma, bronchitis; adrenergic stimulants GLAXO GROUP LIMITED (GB) 1991-02-05 US disclosed